Reference
Qiu D, et al. Chemotherapy combined with Endostar as salvage treatment for EGFR-tyrosine kinase inhibitor primary resistance in an advanced non-small cell lung cancer patient with EGFR L858R mutation and ROS1 fusion: A case report. Thoracic Cancer 10: 1023-1028, No. 4, Apr 2019. Available from: URL: https://doi.org/10.1111/1759-7714.13003 - China
Rights and permissions
About this article
Cite this article
Cisplatin/endostatin/pemetrexed. Reactions Weekly 1751, 98 (2019). https://doi.org/10.1007/s40278-019-61231-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-61231-6